June 2007. Volume 3. Number 2

External validity In randomised controlled trials: considerations

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

MBE | Bases of evidence based medicine

Author: Gervás J1.
1Médico general, Equipo CESCA, Madrid. España.
Correspondence: Juan Gervás . Email: jgervasc@meditex.es
Acceptance date: 25/05/2010
Publication date: 01/06/2007

How to cite this article

Gervás J . Algunas consideraciones en torno a la selección de la muestra y a la validez externa de los ensayos clínicos. Evid Pediatr 2007;3:53.

MBE | Bases of evidence based medicine

Author: Gervás J1.
1Médico general, Equipo CESCA, Madrid. España.
Correspondence: Juan Gervás . Email: jgervasc@meditex.es
Acceptance date: 25/05/2010
Publication date: 01/06/2007

How to cite this article

Gervás J . Algunas consideraciones en torno a la selección de la muestra y a la validez externa de los ensayos clínicos. Evid Pediatr 2007;3:53.

References

  1. Gérvas J, Pérez Fernández M. El diseño semi-experimental y la investigación evaluativa. Aten Primaria. 1991;8:567-76.
  2. Editorial. El referente: el ensayo clínico. Informatiu Agencia d’Avalució de Tecnologìa y Recerca Mèdiques. 2003;31:1-2.
  3. Streptomycin in Tuberculosis Trials Committee. Streptomycin treatment of pulmonary tuberculosis. BMJ. 1948;30:769-82.
  4. Crofton J. The MRC randomized trial of streptomycin and its legacy: a view from the clinical front line. J R Soc Med. 2006;99:531-4.
  5. Hill GB. Archie Cochrane and his legacy. An internal challange to physicians’s autonomy. J Clin Epidemiol. 2000;53:1193-9.
  6. Cochrane A. Eficacia y eficiencia. Relexiones al azar sobre los servicios sanitarios. Barcelona: Salvat; 1985.
  7. Links M. Analogies between reading of medical and religious texts. BMJ. 2006;333:1068-70.
  8. Graham RP, James PA, Cown TM. Are clinical practice guidelines valid for primary care?. J Clin Epidemiol. 2000;53:949-54.
  9. Vallvé C. Revisión crítica del ensayo clínico pragmático. Med Clín (Barc). 2003;121:384-8.
  10. Barton S. Which clinical studies provide the best evidence. The best RCT still trumps the best observational study. BMJ. 2000;321:255-66.
  11. Benson K, Hartz AJ. A comparison of observational studies and randomized controlled trials. N Engl J Med. 2000;342-86.
  12. Concato J, Horwitz RI. Beyond randomised versus observational studies. Lancet. 2004;363:1660-1.
  13. Starfield B. Quality of care research. Internal elegance and external relevance. JAMA. 1998;280:1006-8.
  14. Fletcher RH. Evaluation of interventions. J Clin Epidemiol. 2002;55:1183-90.
  15. Rothwell PM. External validity of randomised controlled trials: “to whom do the results of this trial apply”. Lancet. 2005;365:82-93.
  16. Pereira D. Evidence-based medicine and patient-centred medicine: the need to harmonize. J Health Serv Res Policy. 2005;10:66-8.
  17. Gérvas J, Pérez Fernández M. Uso apropiado de la medicina basada en pruebas: revisión de diez artículos recientes. AMF. 2005;1:46-6.
  18. Feinstein AR. The problem of cogent subgroups: a clinicostatistical tragedy. J Clin Epidemiol. 1998;51:297-9.
  19. Gross CP, Mallory R, Helat A, Krumholz HM. Reporting the recruitment process in clinical trials: who are these patients and how did they get there?. Ann Intern Med. 2002;137:10-6.
  20. Roovers EA, Boere-Boonekamp MM, Castelein RM, Zielhuis GA, Kerkhoff TH. ffectiveness of ultrasound screening for developmental dysplasia of the hip. Arch Dis Child Fetal Neonatal Ed. 2005;90:F25-30.
  21. Perdikidis L, González de Dios J. El cribado ecográfico de displasia de desarrollo de caderas sólo se justifica en recién nacidos con determinados factores de riesgo. Evid Pediatr. 2005;1:4.
  22. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study: final results. Circulation. 1991;184:527-39.
  23. Mant D. Can randomised trials inform clinical decisions about individual patients?. Lancet. 1999;353:743-6.
  24. Schulz KF, Grimes DA, Altman DG, Hayes JR. Blinding and exclusions after allocation in randomised controlled trials:survey of published parallel group trials in obstetrics and gynecology. BMJ. 1996;312:742-4.
  25. Sackett DL. Participants in research. BMJ. 2005;330:1164.
  26. McPherson K, Britton A, Wennberg J. Are randomised controlled trials controlled? Patients preferences and unblind trials. J R Soc Med. 1997;90:652-6.
  27. Flum DR. Interpreting surgical trials with subjective outcomes: avoiding UnSPORTsmanlike conduct. JAMA. 2006;296:2483-5.
  28. Olschewski M, Schumacher M, Davis KB. Analysis of randomised and non-randomised patients in clinical trials using the comprehensive cohort follow-up study design. Control Clin Trials. 1992;13:226-39.
  29. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trial. Lancet. 2000;355:1064-9.
  30. Lee KJ, Thompson SG. Clustering by health professional in individually randomised trials. BMJ. 2005;330:142-4.
  31. Hollis S, Campbell F. What is meant by intention to treat analysis?. Survey of published randomised controlled trials. BMJ. 1999;319:670-4.
  32. Gérvas J. Experiencia, ciencia y “medicina basada en pruebas” en atención primaria. SEMERGEN. 2002;28:302-4.
  33. Alonso-Coello P, García JM, Solá I. Limitaciones y subterfugios de la crítica a la medicina basada en la evidencia. Med Clín (Barc). 2005;124:237-8.
  34. Navarro MA, Ruiz F, Reyes A, Gutiérrez I, Hermosilla T, Alonso C, et al. ¿Las guías que nos guían son fiables?. Evaluación de las guías de práctica clínica españolas. Rev Clín Esp. 2005;205:533-40.
  35. Longford NT, Nelder JA. Statistics versus statistical science in the regulatory process. Statistics Med. 1999;18:2311-20.
  36. Schmoor C, Olschewski M, Schumacher M. Randomized and non-randomized patients in clinical trials: experiences with comprehensive cohort studies. Statistics Med. 1996;15:263-71.
  37. Longford NT. Selection bias and treatment heterogeneity in clinical trials. Statistics Med. 1999;18:1467-74.
  38. Kravitz RL, Duan N, Braslow J. Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. Milbank Q. 2004;4:661-87.
  39. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinasa for acute ischemic stroke. The PROACT ll Study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003-11.
  40. Steinberg EP, Luce BR. Evidence based?. Caveat emptor!. Health Affairs. 2005;24:80-92.
01/06/2007

Linked Comment